Erstellt von fchar99
Insmed Inc. diskutieren
Insmed Inc.
WKN: A1JJA3 / Symbol: INSM / Name: Insmed / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
165,00 €
-0,60 %
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Mizuho from $96.00 to $110.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $100.00 to $112.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $90.00 to $111.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at Morgan Stanley from $102.00 to $108.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $119.00 to $130.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed, Inc. (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at UBS Group AG.
Ratings data for INSM provided by MarketBeat
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at Royal Bank Of Canada from $108.00 to $120.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at Jefferies Financial Group Inc. from $129.00 to $148.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at Mizuho from $130.00 to $165.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $114.00 to $142.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed, Inc. (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at HC Wainwright.
Ratings data for INSM provided by MarketBeat
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at Stifel Nicolaus from $121.00 to $145.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at Truist Financial Corporation from $126.00 to $139.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $111.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its price target raised by analysts at Wells Fargo & Company from $140.00 to $171.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its price target raised by analysts at Guggenheim from $125.00 to $172.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its price target raised by analysts at TD Cowen from $154.00 to $193.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for INSM provided by MarketBeat
Neueste Beiträge
Wells_Fargo___Compan in Weight Watchers International diskutieren